Transcript Highlights:

• Texas is the first state in the country to stand up to the FDA regarding the fact that, one, we have
• We had a very obstructionist FDA at the time.

Bills: HJR34, HB6, HB18, HB39, HB107, HB114, HB138, HB247, HB300, HB647, HB748, HB762, HB793, HB1240, HB1275, HB1397, HB1584, HB1700, HB1875, HB1894, HB1965, HB2071, HB2254, HB2340, HB2350, HB2516, HB2712, HB2713, HB2715, HB2760, HB2842, HB3088, HB3104, HB3260, HB3479, HB3575, HB3687, HB3788, HB4163, HB4187, HB4205, HB4370, HB4384, HB4655, HB4753, HB4809, HB4850, HB5195, HCR90, HCR98, SJR60, SB203, SB317, SB719, SB801, SB867, SB1071, SB1232, SB1319, SB1483, SB1633, SB1798, SB1978, SB2233, SB2363, SB2603, SB2607, SB2717, SB2797, SB2841, SB2928, SB3038, SJR5, SB4, SB9, SB21, SB23, SB27, SB34, SB40, SB75, SB213, SB458, SB482, SB493, SB840, SB841, SB843, SB912, SB1241, SB1253, SB1350, SB1388, SB1423, SB1535, SB1559, SB1789, SB1951, SB2037, SB2143, SB2155, SB2544, SB1, SB17, SB260, SB509, SB1506, SB1637, SB1833, SB2308, HB2525, HJR34, HB1393, HB26, HB388, HB2712, HB1633, HB685, HB762, HB2286, HB1606, HB1458, HB1240, HB2791, HB3146, HB1397, HB2061, HB647, HB4738, HB2563, HB128, HB581, HB766, HB2259, HB2358, HB4384, HB748, HB793, HB1734, HB2340, HB2350, HB3104, HB5180, HB1584, HB3806, HB3804, HB3803, HB1522, HB3597, HB1612, HB4224, HB1314, HB2254, HB1237, HB3126, HB2856, HB3114, HB3505, HB4205, HB5652, HB3687, HB2025, HB3395, HB2495, HB138, HB18, HB1700, HB4655, HB2516, HB1894, HB1965, HB300, HB2713, HB39, HB114, HB24, HB3088, HB4163, HB3479, HB2842, HB519, HB609, HB1275, HB1592, HB3348, HB120, HB6, HB247, HB1533, HB2421, HB2273, HB2464, HB2011, HB3575, HB3788, HB4370, HB4809, HB5057, HB5084, HB5534, HB5668, HB3424, HB2715, HB2564, HB2760, HB2765, HB2898, HB3260, HB3800, HB4396, HB5195, HB4341, HB43, HB5686, HB2467, HB2468, HB2518, HB4310, HB4386, HB4490, HB180, HB5323, HB2, HB149, HB4945, HB2434, HB2529, HB3161, HB3745, HB4044, HB5155, HB5667, HB4996, HB2697, HB2492, HB2355, HB2282, HB2001, HB1902, HB1866, HB1445, HB1443, HB1306, HB1024, HB908, HB305, HB285, HB449, HB171, HB47, HB3464, HB2637, HB4263, HB5436, HB4429, HB3986, HB3966, HB3510, HB2560, HB2026, HB2688, HB4076, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB1978, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB1749, SB2549, SB2553, SB2919, SB1944, SB1232, SB1798, SB2603, SB2607, SB2683, SB1319, SB3038, SB3045, SB1538, SB719, SB3071, SB3065, SB823, SB3062, SB719, HB39, HB114, HB138, HB247, HB300, HB762, HB793, HB1275, HB1584, HB1700, HB1894, HB1965, HB2254, HB2340, HB2350, HB2760, HB2842, HB3088, HB3104, HB3260, HB3479, HB3575, HB3687, HB3788, HB4163, HB4205, HB4370, HB4655, HB4809, HB5195, SB1978, SR508, HJR34, SB963, SB1383, SB1883, SB1968, HB2525, HB112, HB117, HB557, HB783, HB869, HB876, HB1039, HB1201, HB1347, HB1359, HB1650, HB1788, HB1904, HB1955, HB2370, HB2849, HB2853, HB3066, HB3169, HB3178, HB3179, HB3196, HB3241, HB3567, HB3672, HB3715, HB3720, HB3883, HB3954, HB3976, HB4070, HB4098, HB4222, HB4327, HB4359, HB4412, HB4683, HB4755, HB4894, HB4926, HB5115, HB5165, HB5320, HB5437, HB5499, HB5596, HB5650, HB5651, HB5654, HB5656, HB5658, HB5659, HB5661, HB5662, HB5665, HB5666, HB5670, HB5671, HB5672, HB5674, HB5676, HB5677, HB5678, HB5679, HB5680, HB5681, HB5682, HB5688, HB5694, HB5695, HB5696, HB5699, HCR46, HCR59, HCR81, HCR83, HCR84, HCR111, HCR142, HB112, HB117, HB557, HB783, HB869, HB876, HB1039, HB1201, HB1347, HB1359, HB1650, HB1788, HB1904, HB1955, HB2370, HB2849, HB2853, HB3066, HB3169, HB3178, HB3179, HB3196, HB3241, HB3567, HB3672, HB3715, HB3720, HB3883, HB3954, HB3976, HB4070, HB4098, HB4222, HB4327, HB4359, HB4412, HB4683, HB4755, HB4894, HB4926, HB5115, HB5165, HB5320, HB5437, HB5499, HB5596, HB5650, HB5651, HB5654, HB5656, HB5658, HB5659, HB5661, HB5662, HB5665, HB5666, HB5670, HB5671, HB5672, HB5674, HB5676, HB5677, HB5678, HB5679, HB5680, HB5681, HB5682, HB5688, HB5694, HB5695, HB5696, HB5699, HCR46, HCR59, HCR81, HCR83, HCR84, HCR111, HCR142

Keywords: HJR 34, constitutional amendment, Texas Constitution, ad valorem tax, property tax exemption, real property, border counties, U.S.-Mexico border, United Mexican States, border security, border security infrastructure, landowner, county tax base, local government, tax relief, property value increase, infrastructure improvements, voter approval, November 2025 ballot, mental health

Transcript Highlights:

• The abortion drug RU-486, also known as mifepristone, is significantly more dangerous than the FDA drug
• The FDA has weakened safeguards for mifepristone.

Bills: SB 6, SB 11, SB 33

Keywords: electric power, interconnection, utilities, ERCOT, large load customers, water supply, sewer service, demand management, school prayer, Bible reading, religious text, public schools, Texas Education Code, student prayer, silent prayer, meditation, religious liberty, First Amendment, Establishment Clause, church and state

Transcript Highlights:

• The abortion drug RU-486, also known as mifepristone, is significantly more dangerous than the FDA drug
• The FDA has weakened safeguards for mifepristone.

Bills: SB6, SB11, SB33

Keywords: electric power, interconnection, utilities, ERCOT, large load customers, water supply, sewer service, demand management, school prayer, Bible reading, religious text, public schools, Texas Education Code, student prayer, silent prayer, meditation, religious liberty, First Amendment, Establishment Clause, church and state

Transcript Highlights:

• Industry will say that FDA says these chemicals are safe.
• However, the FDA has been asleep at the wheel on many critical public health issues and in the case of

Keywords: 988, house, all

Transcript Highlights:

• work with your offices, certainly, to explain both impacts of previous and future decisions within the FDA
• Just be able to ask, you know, when it comes to the FDA.

Keywords: financial regulations, SEC, Comptroller of the Currency, Federal Transit Administration, nominees, Empowering Main Street in America Act, capital formation, economic growth

Summary: The committee meeting focused on several nominees within key financial institutions, including discussions surrounding the SEC, the Federal Transit Administration, and the Comptroller of the Currency. Notable dialogue included concerns over regulatory balance, with various members emphasizing a need to streamline regulations to foster innovation while ensuring accountability and safety for investors. The importance of the proposed 'Empowering Main Street in America Act' was highlighted as a means to facilitate access to capital for small businesses, underlining the current administration's approach towards financial regulations.

Transcript Highlights:

• language in an education code that refers to f-nephrine in one way, an auto-injector, to encompass all FDA-approved
• This last year, the FDA approved the first needless option to f-nephrine, with more in the pipeline.

Keywords: 988, house, all

Transcript Highlights:

• Cannabis is not approved by the FDA, does not have a national drug code, and cannot be processed through
• the Medical cannabis prescriptions follow the same rigorous safety and efficacy standards that the FDA-approved

Transcript Highlights:

• When you talked about neuromodulation, we now have FDA-approved vagal nerve stimulation for stroke recovery
• With no FDA-approved drugs, this is a drug that, while not a magic solution, slows down the progression

Bills: SB5, SJR3, SB 5, SJR 3

Keywords: dementia, research institute, Alzheimer's disease, Parkinson's disease, funding, grants, state health initiatives, research funding, state budget, prevention, healthcare, medical research, Dementia Prevention and Research Institute, disaster relief, flood preparedness, emergency funding, local government support, meteorological forecasting, district apportionment, legislative rules

Transcript Highlights:

• RU-486, followed by Cytotec, is FDA-approved up to 10 weeks.
• RU-486, followed by Cytotec, is FDA-approved up to 10 weeks.
• RU-486, followed by Cytotec, is FDA-approved up to 10 weeks.
• RU-486, followed by Cytotec, is FDA-approved up to 10 weeks.
• RU-486, followed by Cytotec, is FDA-approved up to 10 weeks.

Bills: HB0003, HB0117, HB0041

Keywords: pregnancy centers, abortion, pro-life, healthcare, women's rights, state regulation, civil rights, freedom of speech, informed consent, civil liability, coercion, healthcare rights, law enforcement, death benefits, retirement, survivor support, public safety, 916, all

Transcript Highlights:

• FDA to treat chronic or acute moderate or severe pain.

Keywords: 1182, all

Transcript Highlights:

• FDA to treat chronic or acute moderate or severe pain.

Summary: The caucus reviewed several House and Senate measures, mostly in concurrence form. HB 2611, which clarifies and expands children’s rights in foster care and kinship care, was presented with a Senate amendment requiring quarterly reports on random employee drug screening results at group homes to the Health and Human Services committee chairs; the sponsor intended to concur. HB 2048, on access to non-opioid prescription drug controls, would bar more restrictive utilization controls such as prior authorization or step therapy for clinically appropriate non-opioid pain medications approved by the FDA, with a repeal date of August 31, 2028; the sponsor intended to concur, though one member raised concerns about opioid addiction in tribal communities and asked about stronger warnings and Indian Health Service involvement. HB 2404, changing inter-facility transport procedures, returned from the Senate with only a delayed effective date change, and concurrence was expected. SB 1630, a Senate bill, would create a home and community-based service program for adults who are seriously mentally ill; members noted there was no opposition, but also that the bill appears to have a cost and no appropriation. HB 2950, creating tourism improvement districts, was amended in the Senate to remove a lodging business assessment requirement for destination marketing organizations and allow local governing bodies to approve assessment rates; members confirmed it remained an opt-in/opt-out structure. HB 2995, which rewrites Arizona’s domestic violence framework for legal decision-making and parenting time cases, was amended to make child and victim safety the highest priority, revise court findings and evidence standards, limit mutual domestic violence findings, and add an emergency clause; the sponsor recommended concurrence, though one member asked where the committee stood on the bill. HB 2265, concerning court fees and assessments, was amended to restore courts’ ability to adopt new fees, fines, and surcharges going forward; concurrence was recommended, but county supervisors remained opposed due to concerns about cost shifts. HB 2986, the annual ADEQ omnibus, was amended to merge the recycling fund into the solid waste fee fund and exempt certain public water system infrastructure modifications from plan review; concurrence was expected. The caucus also briefly noted the fiscal year 2027 budget bills, HB 4154 through HB 4169, before adjourning.

Transcript Highlights:

• However, the FDA still retains authority over products, and the FDA has been very clear that hemp-specific
• And if it's a drug, they do have several approved FDA-approved drugs. prohibition on that so hopefully
• still retains authority however the FDA still retains authority over<01:57:50.119> products<01
• :57:51.119> um<01:57:51.560> and<01:57:51.679> the<01:57:51.800> FDA<01:57
• But the FDA is very clear that you cannot have hemp-derived cannabinoids in food or in supplements.

Keywords: 910, house, all

Transcript Highlights:

• And as of this year, last year rather, we had a blood test approved by the FDA for the purposes of diagnosing

Bills: S0578

Keywords: Alzheimer's disease, Alzheimers, dementia, related dementias, brain health, early detection, diagnosis, caregiver support, elderly affairs, Department of Elderly Affairs, Department of Health, public health outreach, memory loss, cognitive decline, healthy aging, clinical trials, community resources, underserved communities, nonprofit, awareness campaign

Summary: The Committee on Fiscal Policy heard CS for SB 57A, the Alzheimer’s Disease Awareness Initiative by Senator Simon. The bill would create a statewide public health awareness campaign through the Department of Elder Affairs to promote early detection and diagnosis, brain health education, awareness of research and clinical trials, and outreach to older adults and higher-risk populations, with the department contracting with nonprofits for education and awareness efforts. Senator Simon and the bill’s supporters emphasized Florida’s high Alzheimer’s prevalence and the need for public education and early intervention. John Strader, representing the Alzheimer’s Association in South Florida and speaking as a caregiver, testified in support and described how early diagnosis and recent medical advances make awareness campaigns more important. He said a local pilot campaign in Miami-Dade led to a more than 30% increase in calls to the association’s helpline. Karen Morillo of AARP Florida and Tyler Jefferson of the Alzheimer’s Association waived in support. Several senators voiced support and personal reflections on the impact of Alzheimer’s on families and caregivers. Senator Osgood asked about funding and whether the initiative would require new appropriations, and Senator Jones urged that the bill be fully funded and recognized Senator Simon’s personal connection to the issue. In closing, Senator Simon spoke emotionally about his mother’s diagnosis and the need to help families find resources earlier. The committee then approved the bill by roll call vote and reported CS for SB 57A favorably before adjourning.

Transcript Highlights:

• number three had already been banned for food use in most of the developed world for years before the FDA
• Anytime you can pivot from a one-pill-kills approach to a manufactured product that uses FDA regulatory
• The FDA has realistically already done the heavy lifting for all states.

Keywords: 995, all

Summary: The Joint Committee on Public Health held a lengthy hearing to take testimony on a wide range of bills related to environmental health, PFAS, medical device chemicals, food access, lead poisoning, air quality, oral health, and school food additives. Chair Driscoll and Chair Decker emphasized that the hearing was for testimony only, no decisions would be made that day, and that written testimony could still be submitted. They also noted the high volume of speakers and asked witnesses to keep remarks brief. A major portion of the hearing focused on PFAS-related legislation, including bills to restrict PFAS in products and food packaging and to create a PFAS remediation trust fund. Municipal officials and advocates described the high costs of PFAS cleanup, especially for drinking water systems, citing Easton’s multimillion-dollar treatment investments and rate increases. Testimony from legislators and advocates argued that Massachusetts should act despite federal uncertainty, and that the state should stop PFAS at the source rather than leaving municipalities and residents to pay for remediation. The committee also heard strong support for a bill banning DEHP in medical devices, with physicians, nurses, and a bill sponsor saying the chemical can leach from IV bags and tubing and that safer alternatives already exist. The committee also heard testimony on bills to establish statewide food truck permitting, with food truck owners and a senator describing the current system as costly, duplicative, and inconsistent across municipalities. Another set of witnesses supported the “Bean New Deal,” which would expand plant-based food options in public institutions, senior nutrition programs, and WIC, citing health, equity, and cost savings. On lead poisoning, housing advocates and a representative backed bills to expand lead-safe housing requirements to all rental units, arguing the current law contributes to discrimination against families with children and leaves too much pre-1978 housing uncertified. The committee also heard support for an outdoor air pollution bill that would create an advisory committee, identify pollution hotspots, expand monitoring, and set reduction targets, with testimony from environmental justice groups, pediatricians, and legislators describing disproportionate asthma and other health harms in overburdened communities. Later testimony addressed oral health bills to create dental therapists and allow dental hygienists to administer nitrous oxide, with supporters saying the measures would expand access, reduce costs, and help underserved patients. The committee also heard testimony on a bill to prohibit harmful food dyes in competitive school foods, with parents describing behavioral and health concerns tied to synthetic dyes. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• Health and Human Services Secretary said he's directed the FDA to reevaluate its approval of safe abortion
• A common and safe medication abortion drug first approved by the FDA in 2000, yes, that would be 25 years
• Medication abortion is the least invasive option for abortion care based on decades of FDA research.

Keywords: 988, house, all

Transcript Highlights:

• the bill does is let physicians treat patients with stem cell therapies that are not approved by the FDA
• And additionally, the FDA regulates biologics used in transplantation, and this includes ensuring the
• The bill concerns only stem cell therapy that is not approved by the FDA.

Summary: The Senate convened with a quorum, opening prayer, Pledge of Allegiance, and a series of introductions recognizing interns, pages, and retiring Senate staff, including Pastor Gary Austin. Leaders also noted ongoing budget talks with the House and said senators would not need to plan on being in Tallahassee the following week. The chamber then moved to third reading and returned messages from the House later in the day. The main floor debate centered on Committee Substitute for House Bill 12.5, the citizen initiative/constitutional amendment bill. Sponsors said the measure was intended to address fraud in the petition process, citing investigations, arrests, pleas, and open cases involving paid circulators and invalid petitions. Opponents argued the bill would make citizen-led amendments far more difficult, expensive, and risky, warning it would chill grassroots participation, burden supervisors of elections, and effectively favor wealthy or corporate-backed efforts. Supporters responded that the bill preserved grassroots petitioning, placed reasonable guardrails on paid circulators and sponsors, and included a provision barring public funds from being used to advocate for or against ballot initiatives. The bill passed 28-10. The Senate also passed several education measures unanimously, including bills tied to Bright Futures, dual enrollment, educator preparation, and broader education policy. Later, the chamber concurred in House amendments on several bills: stem cell therapy legislation clarifying permitted therapies and penalties for improper use of fetal or embryonic tissue; an EKG requirement bill for student athletes with exemptions and partnership options for districts; and a cardiac emergency response bill that renamed the school emergency plan and removed a bill title honoring Rafe McCrone. These measures passed by wide margins, generally 37-0 or 38-0.

Transcript Highlights:

• the bill does is let physicians treat patients with stem cell therapies that are not approved by the FDA
• And additionally, the FDA regulates biologics used in transplantation, and this includes ensuring the
• The bill concerns only stem cell therapy not approved by the FDA. Thank you for the question.

Summary: The Senate opened with prayer, the Pledge of Allegiance, and a series of member introductions recognizing interns, pages, and a retiring Senate employee. Leadership also announced that budget talks with the House were continuing and that senators should not plan to be in next week, with hopes of sharing more budget news soon. The chamber then moved to third reading and took up a major bill on citizen initiatives and constitutional amendments, with sponsors saying it was needed to address documented petition fraud and to protect the integrity of the process. That bill drew extensive debate. Supporters argued that recent investigations showed widespread fraud in petition gathering, that the measure would add reasonable guardrails, and that it would prevent taxpayer-funded government messaging from being used to influence ballot measures. Opponents said the bill would make it much harder for ordinary Floridians to place amendments on the ballot by adding costs, deadlines, registration requirements, fines, and felony exposure, and they warned it would chill grassroots participation and effectively favor wealthy or corporate-backed campaigns. After debate, the Senate passed the bill 28-10. The Senate then adopted several House amendments and concurred on a series of education and public-safety measures, including bills on stem cell therapy, student-athlete electrocardiograms, cardiac emergency planning in schools, school safety, Bright Futures and other education policy items, and educator preparation. Most of those measures passed unanimously or with overwhelming support, and the chamber also recognized additional interns and a long-serving education advocate before recessing and returning to continue with House messages.

Transcript Highlights:

• the bill does is let physicians treat patients with stem cell therapies that are not approved by the FDA
• vascularized human organs for transplantation are carved out under this bill. ...And additionally, the FDA
• The bill concerns only stem cell therapy not approved by the FDA. Thank you for the question.

Summary: The Senate opened with prayer, the Pledge of Allegiance, and a series of introductions recognizing interns, pages, a retiring sergeant-at-arms employee, and advocates visiting for a Prader-Willi Syndrome awareness resolution. Leaders also noted ongoing budget talks with the House and said senators should not plan to be in next week while negotiations continue. The main floor debate centered on Committee Substitute for House Bill 12.5, a citizen-initiative elections bill. Sponsors said it was intended to address petition fraud and protect the integrity of the constitutional amendment process, citing investigations, arrests, and fraudulent petition activity tied to recent initiatives. Opponents argued the bill would make it much harder and more expensive for citizens to place amendments on the ballot, chill volunteer participation, and effectively favor wealthy or corporate interests. After extensive debate, the bill passed 28-10. The Senate then moved through a series of education bills, including measures on Bright Futures, Gold Seal, Florida ABLE, dual enrollment, educator preparation, and broader education policy, all of which passed unanimously. After a recess, the chamber took up House messages and concurred in amendments to bills on stem cell therapy, student athlete ECGs, cardiac emergency response plans, and school safety. Those measures also passed with broad support, with the school safety bill drawing some questions about the Guardian program and child care facilities.

Transcript Highlights:

• or<00:10:52.800> more<00:10:53.360> layoffs Cuts to the state and the CDC and FDA
• Between the cuts at the state level and the CDC and FDA in the last week, we are no longer able to investigate
• Between the cuts at the state level and the CDC and FDA in the last week, we are no longer able to investigate

Keywords: 919, house, all

Summary: The committee heard House File 2591, the “Support Medicaid Not Millionaires Act,” laid over for possible inclusion in the 2025 taxes bill. Chair Gomez said the bill would create a fifth individual income tax tier on very high earners to offset any future federal Medicaid cuts, arguing that proposed federal budget changes would likely reduce Medicaid funding and create a large state budget hole. Gomez and other supporters framed Medicaid as essential for children, long-term care, mental health, substance use treatment, rural hospitals, and families across Minnesota, and criticized federal tax cuts for corporations and wealthy individuals. Several testifiers supported the bill. A SEIU Healthcare worker described how Medicaid supports her care for a disabled son and her own health needs, warning that cuts would threaten home care, hospitals, and nursing homes. A public health employee from the Minnesota Association of Professional Employees said recent state and federal layoffs had already weakened public health capacity and urged additional revenue to backfill losses. Other supporters, including community and faith leaders, said the wealthy and corporations should pay more to protect public services, youth programs, and Medicaid-funded care. A mental health provider testified that most of the people served by her clinic rely on Medicaid and that cuts would harm clinics, rural access, and the broader behavioral health system. Representative Anderson questioned whether the bill would affect Medicaid spending tied to undocumented immigrants and asked for data on MinnesotaCare and federal-state funding shares. Department of Human Services staff clarified that he was referring to MinnesotaCare, not Medicaid, and said Medicaid is generally matched by the federal government while MinnesotaCare does not have the same match. The exchange became contentious when Gomez objected to Anderson’s use of the term “illegal immigrants” and redirected the discussion back to the bill. Anderson also raised concerns about Medicaid fraud and whether the proposal would backfill any federal changes related to fraud enforcement. No vote was taken; the bill was simply laid over.

Transcript Highlights:

• Items five, six, nine, ten, and eleven are all updating due to FDA updates in guidelines.

Summary: The State Insurance Programs Oversight Subcommittee met to review and approve several Employee Benefits Division (EBD) and pharmacy formulary actions. Grant Wallace, director of EBD and the Office of Property Risk, presented a $280,000 Boston Consulting Group contract to help develop the third-party administration RFP, and the committee approved it. The committee also approved the December 2025, January 2026, and February 2026 pharmacy formulary recommendations, along with February 2026 medical drug recommendations. The formulary changes focused on removing prior authorization for injectable migraine CGRPs, replacing a discontinued capsule with a tablet, updating items for FDA guidance, and leaving some drugs not covered when lower-cost alternatives or insufficient efficacy data existed. For February 2026, EBD recommended removing Skyrizi and Renvoke in favor of lower-cost biosimilars and other alternatives, re-tiering several drugs to encourage generics, adding an anti-seizure medication developed by the Department of Defense, and adding a subcutaneous version of Keytruda for faster administration. The medical drug list similarly shifted toward biosimilars and aligned coverage for Skyrizi and Renvoke across pharmacy and medical settings. Members raised broader questions about the impact of new pharmaceutical discount programs such as Trump RX and Mark Cuban Cost Plus, as well as concerns about PBM compliance and whether Navitus might be violating state law or paying affiliate pharmacies more than independent pharmacies. Wallace said the new programs and their effects were still being studied, that EBD was working with Navitus to evaluate pricing opportunities, and that Navitus had said it was in compliance with Rule 118, though additional research and auditing were underway. All items were approved by voice vote, and the meeting adjourned after no further business.